SCHEMBL23490003

SCHEMBL23490003

CC(C)(C)OC(=O)NCC(=O)N1CCC(NC(=O)O[C@@H]2CCN(c3cn[nH]c(=O)c3Cl)C2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ POLB P06746 4/20 0.38
▸ DRD2 P14416 3/20 0.37
▸ DRD3 P35462 1/20 0.37
▸ SIGMAR1 Q99720 1/20 0.36
▸ MAPK8 P45983 1/20 0.36
▸ PIM1 P11309 1/20 0.36
▸ PIM3 Q86V86 1/20 0.36
▸ PIM2 Q9P1W9 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ ROCK2 O75116 1/20 0.35
▸ CKS1B P61024 1/20 0.35
▸ SKP1 P63208 1/20 0.35
▸ SKP2 Q13309 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ TIPARP Q7Z3E1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23490093 1.00 ALDH1A1 (0.39) ALDH1A1KMT2AMEN1TSHRPOLB
SCHEMBL23490005 0.90 TIPARP (0.40) ALDH1A1KMT2APOLBMAPK8KDM4E
SCHEMBL23490002 0.90 ALDH1A1 (0.42) ALDH1A1KMT2AMEN1TSHRPOLB
SCHEMBL23573525 0.90 POLB (0.38) ALDH1A1KMT2APOLBKDM4EHSD17B10
SCHEMBL23573530 0.90 POLB (0.38) ALDH1A1KMT2APOLBKDM4EHSD17B10
SCHEMBL23490329 0.89 POLB (0.42) ALDH1A1POLBL3MBTL1
SCHEMBL23490486 0.89 DRD2 (0.44) ALDH1A1POLBDRD2DRD3PIM1
SCHEMBL23490112 0.87 POLB (0.40) ALDH1A1KMT2APOLBKDM4EHSD17B10
SCHEMBL23489900 0.86 POLB (0.41) ALDH1A1KMT2APOLBKDM4EHSD17B10
SCHEMBL23490398 0.85 POLB (0.40) ALDH1A1KMT2APOLBKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12509444-B2 Compounds and methods for CD73 modulation and indications therefor PLEXXIKON INC. (US) 2025-12-30 — — US disclosed
US-20210198239-A1 COMPOUNDS AND METHODS FOR CD73 MODULATION AND INDICATIONS THEREFOR PLEXXIKON INC. 2021-07-01 — — US disclosed
WO-2021113625-A1 COMPOUNDS AND METHODS FOR CD73 MODULATION AND INDICATIONS THEREFOR PLEXXIKON INC. (US) 2021-06-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210198239-A1 COMPOUNDS AND METHODS FOR CD73 MODULATION AND INDICATIONS THEREFOR ENTPD5, ADORA2A, ENTPD1 ALDH1A1 216/4885KMT2A 3173/4885MEN1 1145/4885
US-12509444-B2 Compounds and methods for CD73 modulation and indications therefor ENTPD5, ADORA1, ADORA2A ALDH1A1 114/4885KMT2A 3779/4885MEN1 1556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback